Market Capitalization (Millions $) |
3,348 |
Shares
Outstanding (Millions) |
48 |
Employees |
- |
Revenues (TTM) (Millions $) |
47 |
Net Income (TTM) (Millions $) |
-130 |
Cash Flow (TTM) (Millions $) |
72 |
Capital Exp. (TTM) (Millions $) |
17 |
Arcellx Inc
Arcellx Inc is a biotechnology company that specializes in developing and commercializing cell therapies for cancer treatment. The company is focused on developing next-generation CAR-T (chimeric antigen receptor T-cell) therapies that are engineered to target and eliminate cancer cells more effectively. Arcellx's technology is designed to enhance the safety and efficacy of CAR-T therapies by incorporating a controllable on-switch and off-switch mechanism, allowing for precise control of the therapy's activity. The company aims to revolutionize cancer treatment by providing more targeted and personalized therapies with improved outcomes for patients.
Company Address: 25 West Watkins Mill Road Gaithersburg 20878 MD
Company Phone Number: 327-0603 Stock Exchange / Ticker: NASDAQ ACLX
ACLX is expected to report next financial results on March 28, 2024. |
|
|